Maree Smith Explained

Maree Therese Smith is an Australian researcher, inventor and innovator based at the University of Queensland and an Emeritus Professor. She is executive director of the Centre for Integrated Preclinical Drug Development, and TetraQ (a drug testing facility), head of the Pain Research Group in the UQ School of Pharmacy, and the inventor and developer of a potential novel treatment for chronic pain, EMA401.[1] [2]

Smith received a 2012 Life Sciences Queensland Industry Award for Excellence,[3] the 2015 Johnson & Johnson Innovation Industry Excellence Award for biotech industry leadership,[4] and the 2016 Australian Academy of Technological Sciences and Engineering Clunies Ross Award for contributions to the application of technology for the benefit of Australia.[5] She was elected a Fellow of the Australian Academy of Health and Medical Sciences in 2015.[6] She was the President of the Australian Pain Relief Association between 2014 and 2016.

Selected Publications

Notes and References

  1. Web site: Professor Maree Smith FTSE - School of Pharmacy - The University of Queensland, Australia . Uq.edu.au . 2016-06-20 . https://web.archive.org/web/20160724154048/http://www.uq.edu.au/pharmacy/maree-smith . 24 July 2016 . dead .
  2. News: University of Queensland Professor Maree Smith Awarded Prestigious Clunies Ross Award. The Daily Telegraph. 2016-06-20.
  3. Web site: Prof. Maree Smith receives Life Sciences award - School of Pharmacy - The University of Queensland, Australia . Uq.edu.au . 2014-03-24 . 2016-06-20 . https://web.archive.org/web/20160613144310/http://www.uq.edu.au/pharmacy/prof-maree-smith-receives-life-sciences-award . 13 June 2016 . dead .
  4. Web site: UQ pain drug inventor and $200m start-up win national awards - UQ News - The University of Queensland, Australia . Uq.edu.au . 2016-06-20.
  5. Web site: Prestigious award for UQ superstar scientist - UQ News - The University of Queensland, Australia . Uq.edu.au . 2016-06-20.
  6. Web site: October 2021 . Fellowship of the Australian Academy of Health and Medical Sciences . 2022-03-11 . Australian Academy of Health and Medical Sciences.
  7. Shepherd . Andrew J. . Rice . Andrew SC. . Smith . Maree T. . 2023-12-01 . Angiotensin II type 2 receptor signalling as a pain target: Bench, bedside and back-translation . Current Opinion in Pharmacology . 73 . 102415 . 10.1016/j.coph.2023.102415 . 38041933 . 1471-4892. free .
  8. Imam . Mohammad Zafar . Ghassabian . Sussan . Kuo . Andy . Cai . Yunxin . Qin . Yajuan . Li . Tingyou . Smith . Maree T. . 2023-07-01 . In Vitro Assessment of the Metabolic Stability of Two Novel Endomorphin-2 Analogs, CYX-5 and CYX-6, in Rat Liver Microsomes . European Journal of Drug Metabolism and Pharmacokinetics . en . 48 . 4 . 463–466 . 10.1007/s13318-023-00828-6 . 37171777 . 2107-0180.
  9. Smith . Maree T. . November 2022 . Nonopioid analgesics discovery and the Valley of Death: EMA401 from concept to clinical trial . PAIN . en-US . 163 . S1 . S15–S28 . 10.1097/j.pain.0000000000002675 . 0304-3959 . 10578428 . 35984369.
  10. Smith . A. E. . Muralidharan . A. . Smith . M. T. . 2022-10-18 . Prostate cancer induced bone pain: pathobiology, current treatments and pain responses from recent clinical trials . Discover Oncology . en . 13 . 1 . 108 . 10.1007/s12672-022-00569-z . 2730-6011 . 9579264 . 36258057.
  11. Web site: